review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.4103/JPBS.JPBS_138_17 |
P8608 | Fatcat ID | release_334umw4iirc5ralqoz2sbdfyha |
P932 | PMC publication ID | 5731004 |
P698 | PubMed publication ID | 29284928 |
P2093 | author name string | Thukanayakanpalayam Ragunathan Yoithapprabhunath | |
Arjun Parameshwar Raveendran | |||
Charanya Duraisamy | |||
Chitturi Ravi Teja | |||
Joseph Joe | |||
Kenniyan Kumar Srichinthu | |||
Periyasamy Tamilthangam | |||
P2860 | cites work | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
RANK is essential for osteoclast and lymph node development | Q24598872 | ||
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche | Q24600542 | ||
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 | ||
Biology of bone metastases | Q27693653 | ||
Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development | Q28119185 | ||
Anoikis: cancer and the homeless cell | Q28278884 | ||
Beyond tumorigenesis: cancer stem cells in metastasis | Q28279788 | ||
Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma | Q28281602 | ||
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting | Q28298681 | ||
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis | Q29547178 | ||
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion | Q29547317 | ||
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts | Q29547605 | ||
New functions for the matrix metalloproteinases in cancer progression | Q29547738 | ||
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited | Q29547915 | ||
Dissemination and growth of cancer cells in metastatic sites | Q29555846 | ||
Metastasis: from dissemination to organ-specific colonization | Q29614295 | ||
A multigenic program mediating breast cancer metastasis to bone | Q29614308 | ||
Metastasis to bone: causes, consequences and therapeutic opportunities | Q29614310 | ||
The distribution of secondary growths in cancer of the breast. 1889 | Q29614314 | ||
Cancer metastasis: building a framework | Q29616783 | ||
Basic mechanisms responsible for osteolytic and osteoblastic bone metastases | Q30441961 | ||
Cell biology of the osteoclast | Q33700885 | ||
Mechanisms of bone metastasis | Q33977526 | ||
Preparing the "soil": the premetastatic niche | Q34187595 | ||
Molecular basis of metastasis. | Q34304177 | ||
Radiological imaging for the diagnosis of bone metastases. | Q34309990 | ||
Positron emission tomography imaging in oncology | Q34391770 | ||
Growth regulatory factors and bone | Q34435604 | ||
The role of growth factors in the repair of bone. Biology and clinical applications. | Q34683755 | ||
Transcription factors in bone: developmental and pathological aspects | Q34735288 | ||
Overview of bone morphogenetic proteins | Q34805680 | ||
Endothelin receptor antagonists | Q36011743 | ||
Mechanisms of cancer metastasis to the bone | Q36027386 | ||
Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells | Q36230062 | ||
Metastasis: recent discoveries and novel treatment strategies | Q36407511 | ||
New signals from the invasive front | Q36488744 | ||
The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis | Q36682096 | ||
Skeletal imaging in metastatic disease | Q36826610 | ||
Metastatic tumors to the jaws and oral cavity | Q36941921 | ||
The bone microenvironment in metastasis; what is special about bone? | Q37028803 | ||
Migratory neighbors and distant invaders: tumor-associated niche cells | Q37100566 | ||
MicroRNAs as regulators of epithelial-mesenchymal transition. | Q37300965 | ||
Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis | Q37360238 | ||
TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand | Q37413745 | ||
Clinical applications of RANK-ligand inhibition | Q37438675 | ||
Metastasis mechanisms | Q37580464 | ||
A short account of metastatic bone disease | Q38255403 | ||
Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. | Q38352647 | ||
Bone scintigraphy--an update | Q38667373 | ||
Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone | Q39116021 | ||
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin | Q39116155 | ||
Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells | Q40221505 | ||
Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8. | Q40324600 | ||
Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity | Q40345048 | ||
Radiographic evaluation of therapeutic response in bony metastases of breast cancer | Q40357751 | ||
Endothelin receptors, second messengers, and actions in bone. | Q40439597 | ||
Cofilin promotes actin polymerization and defines the direction of cell motility | Q40561188 | ||
Metastatic tumors to the jawbones: analysis of 390 cases | Q40565427 | ||
Transforming growth factor-beta induces osteoclast formation in the absence of RANKL. | Q40594156 | ||
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis | Q40602468 | ||
Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity | Q40637903 | ||
Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype | Q40773287 | ||
Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells | Q40784817 | ||
Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium | Q40923257 | ||
Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. | Q41469995 | ||
Production and significance of TGF-beta in AT-3 metastatic cell line established from the Dunning rat prostatic adenocarcinoma | Q41747236 | ||
Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia | Q42371203 | ||
Anoikis and metastatic potential of cloudman S91 melanoma cells. | Q43540288 | ||
Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis | Q43843519 | ||
Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow | Q44894737 | ||
Metastatic tumors to the jaw bones: retrospective analysis from an Indian tertiary referral center | Q44930038 | ||
Osteoprotegerin in prostate cancer bone metastasis. | Q51531894 | ||
Bull's-eyes and halos: useful MR discriminators of osseous metastases. | Q52886406 | ||
Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. | Q55476886 | ||
A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors | Q58450373 | ||
Magnetic resonance imaging of bone metastases: A diagnostic and screening technique | Q59289209 | ||
Preoperative angiography in patients with bone metastases | Q70557606 | ||
Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells | Q74520565 | ||
Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis | Q77180502 | ||
Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer | Q77602071 | ||
Bone stem cells | Q77808012 | ||
The effects of RANK blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone | Q80349655 | ||
P433 | issue | Suppl 1 | |
P304 | page(s) | S15-S22 | |
P577 | publication date | 2017-11-01 | |
P1433 | published in | Journal of Pharmacy and Bioallied Sciences | Q6295744 |
P1476 | title | Molecular Pathogenesis and Diagnostic Imaging of Metastatic Jaw Tumors | |
P478 | volume | 9 |
Search more.